↓ Skip to main content

Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open‐label, dose‐escalation Study

Overview of attention for article published in this source, November 2018
Altmetric Badge

Mentioned by

googleplus
1 Google+ user

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open‐label, dose‐escalation Study
Published by
Wiley, November 2018
DOI 10.1186/s40880-018-0330-z
Pubmed ID
Authors

Qiuyan Chen, Linquan Tang, Na Liu, Feng Han, Ling Guo, Shanshan Guo, Jianwei Wang, Huai Liu, Yanfang Ye, Lu Zhang, Liting Liu, Pan Wang, Yingqin Li, Qingmei He, Xiaoqun Yang, Qingnan Tang, Yang Li, YuJing Liang, XueSong Sun, Chuanmiao Xie, Yunxian Mo, Ying Guo, Rui Sun, Haoyuan Mo, Kajia Cao, Xiang Guo, Musheng Zeng, Haiqiang Mai, Jun Ma

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 51 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 20%
Student > Master 7 14%
Student > Ph. D. Student 4 8%
Lecturer 2 4%
Student > Doctoral Student 2 4%
Other 5 10%
Unknown 21 41%
Readers by discipline Count As %
Medicine and Dentistry 15 29%
Nursing and Health Professions 6 12%
Biochemistry, Genetics and Molecular Biology 3 6%
Agricultural and Biological Sciences 1 2%
Business, Management and Accounting 1 2%
Other 2 4%
Unknown 23 45%